Does filtering rituximab through a 0.22 um filter affect its efficacy or safety profile in patients with a patent foramen ovale?
Abstract
Current evidence does not clarify specific effects of using a 0.22 µm filter on rituximab administration in patients with a patent foramen ovale; general practice supports filtering for safety without impacting efficacy.
Fields of Study & Subjects
Cardiovascular and Diving-Related Complications
Cerebrospinal fluid and hydrocephalus
Pericarditis and Cardiac Tamponade
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 8 January 2026